BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andreasi V, Partelli S, Muffatti F, Manzoni MF, Capurso G, Falconi M. Update on gastroenteropancreatic neuroendocrine tumors. Dig Liver Dis. 2021;53:171-182. [PMID: 32912771 DOI: 10.1016/j.dld.2020.08.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Canakis A, Lee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc 2022; 14(5): 267-290 [DOI: 10.4253/wjge.v14.i5.267] [Reference Citation Analysis]
2 Yang Z, Shi G. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.05.016] [Reference Citation Analysis]
3 Chiti G, Grazzini G, Cozzi D, Danti G, Matteuzzi B, Granata V, Pradella S, Recchia L, Brunese L, Miele V. Imaging of Pancreatic Neuroendocrine Neoplasms. Int J Environ Res Public Health 2021;18:8895. [PMID: 34501485 DOI: 10.3390/ijerph18178895] [Reference Citation Analysis]
4 Zhou Z, Wang Z, Zhang B, Wu Y, Li G, Wang Z. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors. Front Endocrinol (Lausanne) 2021;12:727327. [PMID: 34539577 DOI: 10.3389/fendo.2021.727327] [Reference Citation Analysis]
5 Capurso G, Gaujoux S, de-Madaria E. Editorial: Hot Topics in Pancreatology From Europe-2020. Front Med (Lausanne) 2021;8:724457. [PMID: 34568380 DOI: 10.3389/fmed.2021.724457] [Reference Citation Analysis]
6 Esposito G, Cazzato M, Rinzivillo M, Pilozzi E, Lahner E, Annibale B, Panzuto F. Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study. Dig Liver Dis 2021:S1590-8658(21)00852-5. [PMID: 34903498 DOI: 10.1016/j.dld.2021.11.012] [Reference Citation Analysis]
7 Fang JM, Li J, Shi J. An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(10): 1009-1023 [DOI: 10.3748/wjg.v28.i10.1009] [Reference Citation Analysis]
8 Han D, Li YL, Zhou ZW, Yin F, Chen J, Liu F, Shi YF, Wang W, Zhang Y, Yu XJ, Xu JM, Yang RX, Tian C, Luo J, Tan HY. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms. World J Gastroenterol 2021; 27(21): 2895-2909 [PMID: 34135560 DOI: 10.3748/wjg.v27.i21.2895] [Reference Citation Analysis]